237 related articles for article (PubMed ID: 24330074)
1. Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.
Pan Y; Huang Y; Wang Z; Fang Q; Sun Y; Tong C; Peng K; Wang Y; Miao L; Cai L; Zhao Y; Liang G
J Cell Mol Med; 2014 Feb; 18(2):231-41. PubMed ID: 24330074
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.
Pan Y; Wang Y; Cai L; Cai Y; Hu J; Yu C; Li J; Feng Z; Yang S; Li X; Liang G
Br J Pharmacol; 2012 Jun; 166(3):1169-82. PubMed ID: 22242942
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
[TBL] [Abstract][Full Text] [Related]
4. A Synthetic Curcuminoid Analog, (2
Huang J; Fu J; Liu B; Wang R; You T
Molecules; 2020 Feb; 25(4):. PubMed ID: 32092902
[TBL] [Abstract][Full Text] [Related]
5. Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys.
Wang Y; Fang Q; Jin Y; Liu Z; Zou C; Yu W; Li W; Shan X; Chen R; Khan Z; Liang G
Br J Pharmacol; 2019 Jul; 176(14):2642-2657. PubMed ID: 30959575
[TBL] [Abstract][Full Text] [Related]
6. Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
Clotet-Freixas S; Soler MJ; Palau V; Anguiano L; Gimeno J; Konvalinka A; Pascual J; Riera M
Lab Invest; 2018 Sep; 98(9):1237-1249. PubMed ID: 29884907
[TBL] [Abstract][Full Text] [Related]
7. H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation.
Xue H; Yuan P; Ni J; Li C; Shao D; Liu J; Shen Y; Wang Z; Zhou L; Zhang W; Huang Y; Yu C; Wang R; Lu L
PLoS One; 2013; 8(9):e74366. PubMed ID: 24058553
[TBL] [Abstract][Full Text] [Related]
8. Novel roles of the renal angiotensin-converting enzyme.
Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Spinal Angiotensin II System in Streptozotocin-Induced Diabetic Neuropathic Pain in Mice.
Ogata Y; Nemoto W; Nakagawasai O; Yamagata R; Tadano T; Tan-No K
Mol Pharmacol; 2016 Sep; 90(3):205-13. PubMed ID: 27401876
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and its receptors in the diabetic kidney.
Burns KD
Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
[TBL] [Abstract][Full Text] [Related]
11. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
[TBL] [Abstract][Full Text] [Related]
12. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
13. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice.
Ichihara A; Suzuki F; Nakagawa T; Kaneshiro Y; Takemitsu T; Sakoda M; Nabi AH; Nishiyama A; Sugaya T; Hayashi M; Inagami T
J Am Soc Nephrol; 2006 Jul; 17(7):1950-61. PubMed ID: 16738017
[TBL] [Abstract][Full Text] [Related]
14. Specific MAPK inhibitors prevent hyperglycemia-induced renal diseases in type 1 diabetic mouse model.
Hong Z; Hong Z; Wu D; Nie H
Mol Cell Biochem; 2016 Aug; 419(1-2):1-9. PubMed ID: 27389030
[TBL] [Abstract][Full Text] [Related]
15. The Absence of the ACE N-Domain Decreases Renal Inflammation and Facilitates Sodium Excretion during Diabetic Kidney Disease.
Eriguchi M; Bernstein EA; Veiras LC; Khan Z; Cao DY; Fuchs S; McDonough AA; Toblli JE; Gonzalez-Villalobos RA; Bernstein KE; Giani JF
J Am Soc Nephrol; 2018 Oct; 29(10):2546-2561. PubMed ID: 30185469
[TBL] [Abstract][Full Text] [Related]
16. Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
Bertoncello N; Moreira RP; Arita DY; Aragão DS; Watanabe IK; Dantas PS; Santos R; Mattar-Rosa R; Yokota R; Cunha TS; Casarini DE
J Diabetes Res; 2015; 2015():674047. PubMed ID: 26442284
[TBL] [Abstract][Full Text] [Related]
17. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
[TBL] [Abstract][Full Text] [Related]
19. Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy.
Malek V; Sharma N; Sankrityayan H; Gaikwad AB
Life Sci; 2019 Mar; 221():159-167. PubMed ID: 30769114
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
